SCHEMBL13040233

SCHEMBL13040233

CNCCOCCOCCNC(=O)COCC(=O)NCCOCCOCCNC(=O)COCC(C)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ CES2 O00748 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ FAAH O00519 1/20 0.33
▸ TSHR P16473 2/20 0.33
▸ NCF1 P14598 1/20 0.33
▸ RECQL P46063 1/20 0.33
▸ CA2 P00918 3/20 0.32
▸ CA12 O43570 2/20 0.32
▸ CA1 P00915 2/20 0.32
▸ CA4 P22748 2/20 0.32
▸ CA9 Q16790 2/20 0.32
▸ CA14 Q9ULX7 2/20 0.32
▸ GLP1R P43220 5/20 0.32
▸ SLC9A3 P48764 1/20 0.31
▸ HPGD P15428 2/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13034764 1.00 MEN1 (0.41) MEN1KMT2ACES2SMN1; SMN2FAAH
SCHEMBL7006602 1.00 MEN1 (0.41) MEN1KMT2ACES2SMN1; SMN2FAAH
SCHEMBL19544555 0.97 MEN1 (0.41) MEN1KMT2ACES2SMN1; SMN2FAAH
SCHEMBL21440855 0.97 MEN1 (0.41) MEN1KMT2ACES2SMN1; SMN2FAAH
SCHEMBL21440826 0.97 MEN1 (0.41) MEN1KMT2ACES2SMN1; SMN2FAAH
SCHEMBL12118184 0.97 MEN1 (0.41) MEN1KMT2ACES2SMN1; SMN2FAAH
SCHEMBL12641023 0.97 MEN1 (0.41) MEN1KMT2ACES2SMN1; SMN2FAAH
SCHEMBL15942666 0.93 CES2 (0.40) MEN1KMT2ACES2FAAHTSHR
SCHEMBL21242896 0.92 CES2 (0.42) MEN1KMT2ACES2SMN1; SMN2FAAH
SCHEMBL21242622 0.92 CES2 (0.42) MEN1KMT2ACES2SMN1; SMN2FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9377465-B2 Rapid and sensitive method for detection of biological targets DAKO DENMARK A/S (DK) 2016-06-28 — — US disclosed
US-9377465-B2 Rapid and sensitive method for detection of biological targets DAKO DENMARK A/S (DK) 2016-06-28 — — US disclosed
US-20100285467-A1 RAPID AND SENSITIVE METHOD FOR DETECTION OF BIOLOGICAL TARGETS DAKO DENMARK A/S (DK) 2010-11-11 — — US disclosed
US-20100285467-A1 RAPID AND SENSITIVE METHOD FOR DETECTION OF BIOLOGICAL TARGETS DAKO DENMARK A/S (DK) 2010-11-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100285467-A1 RAPID AND SENSITIVE METHOD FOR DETECTION OF BIOLOGICAL TARGETS MPO, AOX1, MKI67 MEN1 4684/4885KMT2A 3498/4885CES2 232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback